المؤلفون: Gien LT; Sunnybrook Odette Cancer Centre, Toronto, ONT M4N 3M5, USA. Electronic address: lilian.gien@sunnybrook.ca., Enserro DM; NRG Statistical Center, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA. Electronic address: EnserroD@nrgoncology.org., Block MS; Mayo Clinic, Rochester, MN 55905, USA. Electronic address: Block.Matthew@mayo.edu., Waggoner S; Case Western Reserve University, Cleveland, OH 44195, USA. Electronic address: waggons@ccf.org., Duska LR; University of Virginia Cancer Center, University of Virginia School of Medicine, Charlottesville, VA 22903, USA. Electronic address: lrd5d@virginia.edu., Wahner-Hendrickson AE; Mayo Clinic, Rochester, MN 55905, USA. Electronic address: Wahner-Hendrickson.Andrea@mayo.edu., Thaker PH; Washington University and Siteman Cancer Center, St. Louis, MO 63110, USA. Electronic address: thakerp@wustl.edu., Backes F; Ohio State University Comprehensive Cancer Center, Hilliard, OH 43026, USA. Electronic address: Floor.Backes@osumc.edu., Kidd M; Montana Cancer Society NCORP, Billings Clinic Cancer Center, Billings, MT 59101, USA. Electronic address: mkidd@billingsclinic.org., Muller CY; New Mexico Minority Underserved NCORP, UNM Comprehensive Cancer Center, Albuquerque, NM 87131, USA. Electronic address: cmuller@salud.unm.edu., DiSilvestro PA; Women & Infants Hospital, Providence, RI 02905, USA. Electronic address: pdisilvestro@wihri.org., Covens A; Sunnybrook Odette Cancer Centre, Toronto, ONT M4N 3M5, USA. Electronic address: Al.Covens@sunnybrook.ca., Gershenson DM; University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address: DGershen@mdanderson.org., Moore KN; Oklahoma University Health Stephenson Cancer Center, Oklahoma City, OK 73104, USA. Electronic address: Kathleen-Moore@ouhsc.edu., Aghajanian C; Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Electronic address: aghajanc@mskcc.org., Coleman RL; US Oncology Network, 9180 Pinecroft Ave., Shenandoah, TX 77030, USA. Electronic address: Robert.Coleman@usoncology.com.

المصدر: Gynecologic oncology [Gynecol Oncol] 2024 Jul; Vol. 186, pp. 61-68. Date of Electronic Publication: 2024 Apr 10.

نوع المنشور: Journal Article; Clinical Trial, Phase II

بيانات الدورية: Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-6859 (Electronic) Linking ISSN: 00908258 NLM ISO Abbreviation: Gynecol Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal, Humanized*/adverse effects , Antibodies, Monoclonal, Humanized*/therapeutic use , Antibodies, Monoclonal, Humanized*/administration & dosage , Ovarian Neoplasms*/drug therapy , Ovarian Neoplasms*/pathology , Ovarian Neoplasms*/mortality , Neoplasm Recurrence, Local*/drug therapy , Neoplasm Recurrence, Local*/pathology , Sulfonamides*/administration & dosage , Sulfonamides*/adverse effects , Sulfonamides*/therapeutic use , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Antineoplastic Combined Chemotherapy Protocols*/adverse effects, Humans ; Female ; Middle Aged ; Aged ; Adult ; Aged, 80 and over ; Adenocarcinoma, Clear Cell/drug therapy ; Adenocarcinoma, Clear Cell/pathology ; Adenocarcinoma, Clear Cell/mortality ; Progression-Free Survival ; Oximes

المؤلفون: Kalogera E; Division of Gynecologic Surgery, Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, Minnesota., Nevala WK; Department of Immunology, Mayo Clinic, Rochester, Minnesota., Finnes HD; Department of Pharmacy, Mayo Clinic, Rochester, Minnesota., Suman VJ; Division of Biomedical Statistics and Bioinformatics, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota., Schimke JM; Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, Minnesota., Strand CA; Division of Biomedical Statistics and Bioinformatics, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota., Kottschade LA; Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, Minnesota., Kudgus RA; Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, Minnesota., Buhrow SA; Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, Minnesota., Becher LR; Department of Immunology, Mayo Clinic, Rochester, Minnesota., Geng L; Department of Immunology, Mayo Clinic, Rochester, Minnesota., Glaser GE; Division of Gynecologic Surgery, Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, Minnesota., Grudem ME; Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, Minnesota., Jatoi A; Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, Minnesota., Klampe CM; Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, Minnesota., Kumar A; Division of Gynecologic Surgery, Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, Minnesota., Langstraat CL; Division of Gynecologic Surgery, Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, Minnesota., McWilliams RR; Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, Minnesota., Wahner Hendrickson AE; Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, Minnesota., Weroha SJ; Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, Minnesota., Yan Y; Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, Minnesota., Reid JM; Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, Minnesota., Markovic SN; Department of Immunology, Mayo Clinic, Rochester, Minnesota.; Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, Minnesota., Block MS; Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, Minnesota.

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Jun 14; Vol. 30 (12), pp. 2623-2635.

نوع المنشور: Journal Article; Clinical Trial, Phase I

بيانات الدورية: Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Paclitaxel*/administration & dosage , Paclitaxel*/adverse effects , Paclitaxel*/pharmacokinetics , Albumins*/administration & dosage , Albumins*/adverse effects , Genital Neoplasms, Female*/drug therapy , Genital Neoplasms, Female*/pathology , Bevacizumab*/administration & dosage , Antineoplastic Combined Chemotherapy Protocols*/adverse effects , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Antineoplastic Combined Chemotherapy Protocols*/pharmacokinetics , Antineoplastic Combined Chemotherapy Protocols*/administration & dosage, Humans ; Female ; Middle Aged ; Aged ; Adult ; Immunoconjugates/administration & dosage ; Immunoconjugates/adverse effects ; Immunoconjugates/pharmacokinetics ; Immunoconjugates/therapeutic use ; Treatment Outcome ; Maximum Tolerated Dose

المؤلفون: Liu JF; Dana-Farber Cancer Institute, Boston, MA., Gaillard S; Johns Hopkins University, Baltimore, MD., Wahner Hendrickson AE; Mayo Clinic, Rochester, MN., Yeku O; Massachusetts General Cancer Center, Boston, MA., Diver E; Stanford Women's Cancer Center, Palo Alto, CA., Gunderson Jackson C; Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK., Arend R; University of Alabama at Birmingham, Birmingham, AL., Ratner E; Yale University, New Haven, CT., Samnotra V; GSK, Waltham, MA., Gupta D; GSK, Waltham, MA., Chung J; GSK, Waltham, MA., Zhang H; GSK, Waltham, MA., Compton N; GSK, Brentford, United Kingdom., Baines A; GSK, Stevenage, United Kingdom., Bacqué E; GSK, Waltham, MA., Liu X; GSK, Waltham, MA., Felicetti B; GSK, Stevenage, United Kingdom., Konecny GE; University of California Los Angeles, Los Angeles, CA.

المصدر: JCO precision oncology [JCO Precis Oncol] 2024 May; Vol. 8, pp. e2300693.

نوع المنشور: Journal Article; Clinical Trial, Phase II; Multicenter Study

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: Print Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Ovarian Neoplasms*/drug therapy , Bevacizumab*/therapeutic use , Indazoles*/therapeutic use , Piperidines*/therapeutic use , Piperidines*/adverse effects , Drug Resistance, Neoplasm* , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use, Humans ; Female ; Middle Aged ; Aged ; Adult ; Aged, 80 and over ; Antibodies, Monoclonal, Humanized/therapeutic use ; Cohort Studies

المؤلفون: Konstantinopoulos PA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Cheng SC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Lee EK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., da Costa AABA; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA.; Center for DNA Damage and Repair, Dana-Farber Cancer Institute, Boston, MA., Gulhan D; Department of Biomedical Informatics and Ludwig Center at Harvard, Harvard Medical School, Boston, MA., Wahner Hendrickson AE; Department of Medical Oncology, Mayo Clinic, Rochester, MN., Kochupurakkal B; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA.; Center for DNA Damage and Repair, Dana-Farber Cancer Institute, Boston, MA., Kolin DL; Department of Pathology, Brigham and Women's Hospital, Boston, MA., Kohn EC; Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD., Liu JF; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Penson RT; Department of Medical Oncology, Massachusetts General Hospital, Boston, MA., Stover EH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Curtis J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Sawyer H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Polak M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Chowdhury D; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA., D'Andrea AD; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA.; Center for DNA Damage and Repair, Dana-Farber Cancer Institute, Boston, MA., Färkkilä A; Research Program in Systems Oncology, FIMM and HiLife, University of Helsinki, Helsinki, Finland., Shapiro GI; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Matulonis UA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.

المصدر: JCO precision oncology [JCO Precis Oncol] 2024 Apr; Vol. 8, pp. e2300635.

نوع المنشور: Clinical Trial, Phase II; Randomized Controlled Trial; Multicenter Study; Journal Article

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: Print Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Gemcitabine* , Ovarian Neoplasms*/drug therapy , Isoxazoles* , Pyrazines*, Humans ; Female ; Deoxycytidine/therapeutic use ; Carcinoma, Ovarian Epithelial/drug therapy ; Protein Kinase Inhibitors/therapeutic use ; Ataxia Telangiectasia Mutated Proteins/genetics

المؤلفون: Shafa A; Mayo Clinic, Department of Obstetrics and Gynecology, Division of Gynecologic Surgery, Rochester, MN, United States of America., Watkins AB; Mayo Clinic, Department of Obstetrics and Gynecology, Division of Gynecologic Surgery, Rochester, MN, United States of America., McGree ME; Mayo Clinic, Department of Quantitative Health Sciences, Division of Clinical Trials and Biostatistics, Rochester, MN, United States of America., Weroha SJ; Mayo Clinic, Department of Oncology, Rochester, MN, United States of America., Wahner Hendrickson AE; Mayo Clinic, Department of Oncology, Rochester, MN, United States of America., Block MS; Mayo Clinic, Department of Oncology, Rochester, MN, United States of America., Langstraat CL; Mayo Clinic, Department of Obstetrics and Gynecology, Division of Gynecologic Surgery, Rochester, MN, United States of America; Mayo Clinic, Department of Oncology, Rochester, MN, United States of America., McBane RD 2nd; Mayo Clinic, Department of Cardiovascular Disease, Rochester, MN, United States of America., Bakkum-Gamez JN; Mayo Clinic, Department of Obstetrics and Gynecology, Division of Gynecologic Surgery, Rochester, MN, United States of America., Kumar A; Mayo Clinic, Department of Obstetrics and Gynecology, Division of Gynecologic Surgery, Rochester, MN, United States of America. Electronic address: kumar.amanika@mayo.edu.

المصدر: Gynecologic oncology [Gynecol Oncol] 2023 Sep; Vol. 176, pp. 36-42. Date of Electronic Publication: 2023 Jul 11.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-6859 (Electronic) Linking ISSN: 00908258 NLM ISO Abbreviation: Gynecol Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Ovarian Neoplasms*/drug therapy , Ovarian Neoplasms*/surgery , Ovarian Neoplasms*/pathology , Venous Thromboembolism*/epidemiology , Venous Thromboembolism*/etiology , Venous Thromboembolism*/prevention & control, Humans ; Female ; Carcinoma, Ovarian Epithelial/drug therapy ; Carcinoma, Ovarian Epithelial/surgery ; Carcinoma, Ovarian Epithelial/complications ; Neoadjuvant Therapy/adverse effects ; Anticoagulants/adverse effects ; Incidence ; Retrospective Studies

المؤلفون: O'Cearbhaill RE; Memorial Sloan Kettering Cancer Center, New York, NY, United States of America. Electronic address: ocearbhr@mskcc.org., Miller A; Roswell Park Comprehensive Cancer Center, Buffalo, NY, United States of America. Electronic address: millera@nrgoncology.org., Soslow RA; Memorial Sloan Kettering Cancer Center, New York, NY, United States of America. Electronic address: soslowr@mskcc.org., Lankes HA; NRG Oncology, Operations Center-Philadelphia East, Philadelphia, PA, United States of America; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, The Ohio State University Wexner Medical Center, Columbus, OH, United States of America. Electronic address: lankesh@nrgoncology.org., DeLair D; Northwell Health, Greenvale, New York, NY, United States of America. Electronic address: ddelair@northwell.edu., Segura S; Indiana University School of Medicine, Indianapolis, IN, United States of America. Electronic address: ssegura@iu.edu., Chavan S; Memorial Sloan Kettering Cancer Center, New York, NY, United States of America. Electronic address: schavan@repertoire.com., Zamarin D; Memorial Sloan Kettering Cancer Center, New York, NY, United States of America. Electronic address: zamarind@mskcc.org., DeBernardo R; Case Western University, Cleveland, OH, United States of America. Electronic address: DEBERNR@ccf.org., Moore K; University of Oklahoma, Oklahoma City, OK, United States of America. Electronic address: Kathleen-Moore@ouhsc.edu., Moroney J; University of Chicago, Chicago, IL, United States of America. Electronic address: jwmoroney@bsd.uchicago.edu., Shahin M; Abington Memorial Hospital, Willow Grove, PA, United States of America. Electronic address: Mark.Shahin@jefferson.edu., Thaker PH; Washington University, St. Louis, MO, United States of America. Electronic address: thakerp@wudosis.wustl.edu., Wahner-Hendrickson AE; Mayo Clinic, Rochester, MN, United States of America. Electronic address: WahnerHendrickson.Andrea@mayo.edu., Aghajanian C; Memorial Sloan Kettering Cancer Center, New York, NY, United States of America. Electronic address: aghajanc@mskcc.org.

المصدر: Gynecologic oncology [Gynecol Oncol] 2023 Sep; Vol. 176, pp. 16-24. Date of Electronic Publication: 2023 Jul 05.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-6859 (Electronic) Linking ISSN: 00908258 NLM ISO Abbreviation: Gynecol Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Endometrioid*/drug therapy , Carcinoma, Endometrioid*/genetics , Carcinoma, Endometrioid*/metabolism , Adenocarcinoma, Clear Cell*/drug therapy , Adenocarcinoma, Clear Cell*/genetics , Adenocarcinoma, Clear Cell*/metabolism , Ovarian Neoplasms*/drug therapy , Ovarian Neoplasms*/genetics , Ovarian Neoplasms*/metabolism, Humans ; Female ; Peritoneum/pathology ; Dasatinib/adverse effects ; Fallopian Tubes/pathology ; Endometrium/pathology

المؤلفون: Praiss AM; Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, United States of America. Electronic address: PraissA@mskcc.org., Miller A; NRG Oncology Statistics and Data Center, Roswell Park Cancer Institute, Buffalo, NY, United States of America. Electronic address: MillerA@NRGOncology.org., Smith J; McGovern Medical School, The University of Texas Health Science Center, Houston, TX, United States of America. Electronic address: judith.ann.smith@uth.tmc.edu., Lichtman SM; Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States of America; Department of Medicine, Weill Cornell Medical College, New York, NY, United States of America. Electronic address: LichtmaS@mskcc.org., Bookman M; Department of Medical Oncology, Kaiser-Permanente Northern California, San Francisco, CA, United States of America. Electronic address: Michael.A.Bookman@kp.org., Aghajanian C; Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States of America; Department of Medicine, Weill Cornell Medical College, New York, NY, United States of America. Electronic address: aghajanc@MSKCC.org., Sabbatini P; Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States of America; Department of Medicine, Weill Cornell Medical College, New York, NY, United States of America. Electronic address: sabbatip@mskcc.org., Backes F; Department of Oncology, James Cancer Center, Ohio State University Comprehensive Cancer Center, Columbus, OH, United States of America. Electronic address: Floor.Backes@osumc.edu., Cohn DE; Department of Oncology, James Cancer Center, Ohio State University Comprehensive Cancer Center, Columbus, OH, United States of America. Electronic address: David.Cohn@osumc.edu., Argenta P; Department of Obstetrics, Gynecology and Women's Health, Division of Gynecologic Oncology, University of Minnesota, Minneapolis, MN, United States of America. Electronic address: argenta@umn.edu., Friedlander M; Department of Medical Oncology, Prince of Wales Hospital and Prince of Wales Clinical School, UNSW, Sydney, New South Wales, Australia. Electronic address: Michael.Friedlander@health.nsw.gov.au., Goodheart MJ; Gynecologic Oncology, University of Iowa Hospitals, Iowa City, IA, United States of America. Electronic address: Michael-goodheart@uiowa.edu., Mutch DG; Gynecologic Oncology, Washington University, St. Louis, MO, United States of America. Electronic address: mutchd@wustl.edu., Gershenson DM; Gynecologic Oncology, University of Texas, MD Anderson Cancer Center, Houston, TX, United States of America. Electronic address: dgershen@mdanderson.org., Tewari KS; Gynecologic Oncology, University of California, Irvine Medical Center, Orange, CA, USA. Electronic address: ktewari@uci.edu., Wenham RM; Gynecologic Oncology, Moffitt Cancer Center and Research Institute, Tampa, FL, United States of America. Electronic address: Robert.wenham@moffitt.org., Wahner Hendrickson AE; Division of Medical Oncology, Mayo Clinic, Rochester, MN, United States of America. Electronic address: WahnerHendrickson.Andrea@mayo.edu., Lee RB; Gynecologic Oncology, Tacoma General Hospital, Tacoma, WA, United States of America., Gray H; Gynecologic Oncology, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America. Electronic address: hgray@uw.edu., Secord AA; Gynecologic Oncology, Duke Cancer Institute, Duke University Medical Center, Durham, NC, United States of America. Electronic address: angeles.secord@duke.edu., Van Le L; Gynecologic Oncology, University of North Carolina, United States of America. Electronic address: linda_van_le@med.unc.edu., O'Cearbhaill RE; Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States of America; Department of Medicine, Weill Cornell Medical College, New York, NY, United States of America. Electronic address: ocearbhr@mskcc.org.

المصدر: Gynecologic oncology [Gynecol Oncol] 2023 Jul; Vol. 174, pp. 213-223. Date of Electronic Publication: 2023 May 23.

نوع المنشور: Clinical Trial, Phase III; Journal Article; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-6859 (Electronic) Linking ISSN: 00908258 NLM ISO Abbreviation: Gynecol Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Ovarian Neoplasms*/drug therapy, Female ; Humans ; Carboplatin ; Creatinine ; Glomerular Filtration Rate ; Kidney Function Tests ; Retrospective Studies

المؤلفون: Ehlers SL; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota., Gudenkauf LM; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota., Kacel EL; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota., Hanna SM; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota., Sinicrope PS; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota., Patten CA; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota., Morrison EL; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota., Snuggerud J; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota., Bevis D; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota., Kirsch JL; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota., Staab JP; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota., Price KAR; Department of Oncology, Mayo Clinic, Rochester, Minnesota., Wahner-Hendrickson AE; Department of Oncology, Mayo Clinic, Rochester, Minnesota., Ruddy KJ; Department of Oncology, Mayo Clinic, Rochester, Minnesota.

المصدر: Journal of the National Comprehensive Cancer Network : JNCCN [J Natl Compr Canc Netw] 2023 Jun; Vol. 21 (6), pp. 627-635.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Harborside Press Country of Publication: United States NLM ID: 101162515 Publication Model: Print Cited Medium: Internet ISSN: 1540-1413 (Electronic) Linking ISSN: 15401405 NLM ISO Abbreviation: J Natl Compr Canc Netw Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*, Humans ; Female ; Male ; Medical Oncology ; Comprehensive Health Care ; Patient Satisfaction ; Research Design

المؤلفون: Sia TY; Memorial Sloan Kettering Cancer Center, New York, NY, United States of America. Electronic address: siat@mskcc.org., Tew WP; Memorial Sloan Kettering Cancer Center, New York, NY, United States of America. Electronic address: teww@mskcc.org., Purdy C; Roswell Park Comprehensive Cancer Center, Buffalo, NY, United States of America. Electronic address: purdyc@nrgoncology.org., Chi DS; Memorial Sloan Kettering Cancer Center, New York, NY, United States of America. Electronic address: chid@mskcc.org., Menzin AW; North Shore-Long Island Jewish Medical Center, Manhasset, NY, United States of America. Electronic address: amenzin@northwell.edu., Lovecchio JL; North Shore-Long Island Jewish Medical Center, Manhasset, NY, United States of America. Electronic address: jlovecch@northwell.edu., Bookman MA; Gynecologic Oncology Therapeutics, Kaiser Permanente, San Francisco, CA, United States of America. Electronic address: Michael.A.Bookman@kp.org., Cohn DE; Ohio State University Comprehensive Cancer Center, Columbus, OH, United States of America. Electronic address: David.Cohn@osumc.edu., Teoh DG; University of Minnesota Medical Center, Minneapolis, MN, United States of America. Electronic address: dkteoh@umn.edu., Friedlander M; Department of Medical Oncology, Prince of Wales Hospital and Prince of Wales Clinical School, UNSW, Sydney, New South Wales, Australia. Electronic address: Michael.Friedlander@health.nsw.gov.au., Bender D; University of Iowa Hospitals, Iowa City, IA, United States of America. Electronic address: David-bender@uiowa.edu., Mutch DG; Washington University, St. Louis, MO, United States of America. Electronic address: mutchd@wustl.edu., Gershenson DM; MD Anderson Cancer Center, Houston, TX, United States of America. Electronic address: dgershen@mdanderson.org., Tewari KS; University of California, Irvine, Orange, CA, United States of America. Electronic address: ktewari@hs.uci.edu., Wenham RM; Moffitt Cancer Center and Research Institute, Tampa, FL, United States of America. Electronic address: Robert.wenham@moffitt.org., Wahner Hendrickson AE; Mayo Clinic, Rochester, MN, United States of America. Electronic address: WahnerHendrickson.Andrea@mayo.edu., Lee RB; Tacoma General Hospital, Tacoma, WA, United States of America. Electronic address: rogerblee@aol.com., Gray HJ; Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America. Electronic address: hgray@uw.edu., Secord AA; Duke University Medical Center, Durham, NC, United States of America. Electronic address: angeles.secord@duke.edu., Van Le L; University of North Carolina, Chapel Hill, NC, United States of America. Electronic address: linda_van_le@med.unc.edu., Lichtman SM; Memorial Sloan Kettering Cancer Center, New York, NY, United States of America. Electronic address: LichtmaS@mskcc.org.

المصدر: Gynecologic oncology [Gynecol Oncol] 2023 Jun; Vol. 173, pp. 130-137. Date of Electronic Publication: 2023 May 04.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-6859 (Electronic) Linking ISSN: 00908258 NLM ISO Abbreviation: Gynecol Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Ovarian Neoplasms*/pathology , Neoplasms, Glandular and Epithelial*/drug therapy, Female ; Humans ; Aged ; Carcinoma, Ovarian Epithelial/drug therapy ; Carboplatin ; Disease-Free Survival ; Paclitaxel ; Treatment Outcome ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Neoplasm Staging

المؤلفون: Manzo J; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Pittsburgh, PA, USA., Puhalla S; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Pittsburgh, PA, USA.; Division of Hematology/Oncology, Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA., Pahuja S; Division of Hematology/Oncology, Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA., Ding F; Biostatistics Facility, UPMC Hillman Cancer Center, Pittsburgh, PA, USA., Lin Y; Biostatistics Facility, UPMC Hillman Cancer Center, Pittsburgh, PA, USA.; Department of Biostatistics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA., Appleman L; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Pittsburgh, PA, USA.; Division of Hematology/Oncology, Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA., Tawbi H; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Pittsburgh, PA, USA.; Division of Hematology/Oncology, Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA., Stoller R; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Pittsburgh, PA, USA.; Division of Hematology/Oncology, Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA., Lee JJ; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Pittsburgh, PA, USA.; Division of Hematology/Oncology, Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA., Diergaarde B; Department of Biostatistics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA., Kiesel BF; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Pittsburgh, PA, USA.; Department of Pharmaceutical Sciences, School of Pharmacy, Pittsburgh, PA, USA., Yu J; Department of Pathology, Magee-Womens Hospital of University of Pittsburgh Medical Center, Pittsburgh, USA., Tan AR; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.; Levine Cancer Institute, Charlotte, NC, USA., Belani CP; Penn State Cancer Institute, Penn State College of Medicine, Hershey, PA, USA., Chew H; Division of Hematology/Oncology, Department of Medicine, University of California Davis, Sacramento, CA, USA., Garcia AA; Department of Medicine, Louisiana State University, New Orleans, LA, USA., Morgan RJ; Department of Molecular Pharmacology, City of Hope Beckman Research Institute, Duarte, CA, USA., Wahner Hendrickson AE; Department of Oncology, Mayo Clinic, Rochester, MN, USA., Visscher DW; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA., Hurley RM; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, USA., Kaufmann SH; Department of Oncology, Mayo Clinic, Rochester, MN, USA.; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, USA., Swisher EM; Department of Obstetrics and Gynecologic, University of Washington, Seattle, WA, USA., Oesterreich S; Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA., Katz T; Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA., Ji J; Clinical Pharmacodynamic Biomarkers Program, Applied/Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Zhang Y; Clinical Pharmacodynamic Biomarkers Program, Applied/Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Parchment RE; Investigational Drug Branch, Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA., Chen A; Investigational Drug Branch, Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA., Duan W; Department of Human and Molecular Genetics, The Florida International University, Miami, FL, USA., Giranda V; AbbVie Laboratories, North Chicago, IL, USA., Shepherd SP; AbbVie Laboratories, North Chicago, IL, USA., Ivy SP; Investigational Drug Branch, Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA., Chu E; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Pittsburgh, PA, USA.; Division of Hematology/Oncology, Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA., Beumer JH; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Pittsburgh, PA, USA. beumerj@gmail.com.; Division of Hematology/Oncology, Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA. beumerj@gmail.com.; Department of Pharmaceutical Sciences, School of Pharmacy, Pittsburgh, PA, USA. beumerj@gmail.com.

مؤلفون مشاركون: ETCTN-8282 study team

المصدر: Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2022 May; Vol. 89 (5), pp. 721-735. Date of Electronic Publication: 2022 Apr 18.

نوع المنشور: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0843 (Electronic) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE

مواضيع طبية MeSH: Lymphopenia*/chemically induced , Lymphopenia*/drug therapy , Ovarian Neoplasms*/drug therapy , Ovarian Neoplasms*/genetics , Triple Negative Breast Neoplasms*/drug therapy, Antineoplastic Combined Chemotherapy Protocols ; BRCA1 Protein/genetics ; BRCA2 Protein/genetics ; Benzimidazoles ; Female ; Humans ; Nausea/chemically induced ; Platinum/therapeutic use ; Poly(ADP-ribose) Polymerase Inhibitors/adverse effects ; Seizures/chemically induced